Ranking Member Cassidy Opens Investigation into Hospital Revenue Generated by 340B Drug Program
Issues: Health and Health Care
"The 340B Program is regularly reviewed by the Government Accountability Office (GAO) and HHS's Office of Inspector General (OIG), both of which have highlighted issues with the program. GAO has identified the troubling recent pattern of 340B covered entities increasingly serving wealthier communities with higher rates of insurance, which is far afield from the program's intent. Additionally, GAO has found that covered entities often do not share 340B discounts directly with their patients."
Source